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Background: The interaction of MSP119 with 
the cupredoxin azurin inhibits the growth of 
Plasmodium falciparum in red blood cells.  
Results: Rusticyanin forms a well-defined 
complex with MSP119 upon binding at the 
same surface area than inhibitory antibodies.  
Conclusion: Rusticyanin becomes an 
excellent therapeutic agent for malaria. 
Significance: Knowing the rusticyanin-
MSP119 interface will allow the design of 
novel anti-malarial drugs. 
 
SUMMARY  
The discovery of effective new 
antimalarial agents is urgently needed. One 
of the most frequently-studied molecules 
anchored to the parasite surface is the 
merozoite surface protein-1 (MSP1). At red 
blood cell invasion MSP1 is proteolytically 
processed and the 19 kDa C-terminal 
fragment (MSP119) remains on the surface 
and is taken into the red blood cell, where it 
is transferred to the food vacuole and 
persists until the end of the intracellular 
cycle. Since a number of specific antibodies 
inhibit erythrocyte invasion and parasite 
growth, MSP119 is therefore a promising 
target against malaria. Given the structural 
homology of cupredoxins with the Fab 
domain of monoclonal antibodies, an 
approach combining NMR and ITC 
measurements with docking calculations 
based on BiGGER is employed on MSP119-
cupredoxin complexes. Among the 
cupredoxins tested, rusticyanin forms a 
well-defined complex with MSP119 at a site 
that overlaps with the surface recognized 
by the inhibitory antibodies. The addition 
of holo-rusticyanin to infected cells results 
in parasitemia inhibition, but negligible 
effects on parasite growth can be observed 
for apo-rusticyanin and other proteins of 
the cupredoxin family. These findings point 
to rusticyanin as an excellent therapeutic 
tool for malaria treatment and provide 
valuable information for drug design.  
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Malaria is a widely-spread disease 
causing morbidity and mortality throughout a 
large part of the world. The increasing 
resistance of Plasmodium falciparum, the 
causative agent of the most deadly form of the 
disease, to current drugs has only increased 
the urgency for finding new anti-malarial 
agents (1,2), including an effective vaccine 
and new drug therapies (3,4). There are five 
Plasmodium species that infect humans, while 
others infect other primates or rodents. 
Among this latter group, rodent parasites such 
as Plasmodium yoelii provide useful 
laboratory models for the study of malaria. 
The disease is caused by the replication and 
multiplication of the asexual blood stages in 
red blood cells. The merozoite form of the 
parasite invades the host cell, where it 
develops and replicates to form several new 
merozoites that then burst out of the cell to 
continue the cycle of invasion and 
multiplication. The invasion of red blood cells 
requires an initial recognition and binding 
mediated by parasite surface ligands, followed 
by reorientation and the formation of a 
moving junction between the erythrocyte and 
merozoite surfaces as the parasite enters the 
cell. Merozoite surface protein-1 (MSP1)6 has 
been implicated in this initial binding between 
parasite and host cell. 
Located on the surface of the asexual 
blood-stage schizont and merozoite, MSP1 is 
one of the most frequently-studied molecules 
of the parasite (5). It is synthesized as a ~200-
kDa precursor attached to the surface of the 
parasite via a glycosylphosphatidylinositol 
(GPI) anchor, which undergoes a two-step 
proteolytic process: first, at merozoite release 
and, then, at erythrocyte invasion (6). As a 
result of this processing, the MSP1 is cleaved 
into several polypeptides that are shed from 
the surface in the final processing step, save a 
19 kDa C-terminal fragment (MSP119). 
MSP119 is retained on the parasite surface by 
the GPI anchor and taken into the red blood 
cell at invasion (7-9). The role of MSP119 in 
the subsequent intracellular development of 
the parasite is poorly understood, although it 
is transferred to the developing food vacuole, 
where it remains until the end of the 
intracellular cycle, and is discarded in the 
residual body together with products of 
hemoglobin digestion such as hemozoin (10). 
MSP119 is considered a promising malaria 
vaccine candidate due to the abundant 
evidence of specific antibodies inhibiting 
erythrocyte invasion and parasite growth, for 
instance, via the disruption of  MSP1 
proteolytic processing and intracellular 
parasite development (11). 
At the structural and functional levels, 
MSP119 is particularly well-conserved among 
Plasmodium species (Figure 1) (12-17) and its 
three-dimensional structure has been shown to 
consist of two epidermal growth factor (EGF)-
like domains in close contact. A characteristic 
disulphide-bridge pattern (Figure 1) makes 
MSP119 highly resistant to proteases (19) and 
may explain why MSP119 remains intact in the 
digestive food vacuole up to the end of the 
intracellular cycle (10).  
MSP1-specific immunoglobulins react 
with conformational epitopes of MSP119. 
Some of these antibodies inhibit parasite 
invasion of erythrocytes, whereas others do 
not. Fine-structure epitope mapping of 
different monoclonal antibodies (mAbs) and 
the use of NMR methods indicates the binding 
of two inhibitory antibodies to epitopes on one 
side of the molecule near the interface 
between the two EGF domains, including 
residues from both domains (20,21). By 
contrast, non-inhibitory neutral mAbs bind 
elsewhere on the molecule (15, 20). Here we 
have used MSP119 from P. yoelii, a rodent 
malaria parasite used as a laboratory model 
for vaccine studies (22) and for which both 
inhibitory and neutral antibodies have been 
partially mapped on the structure (23, 24, 
Curd et al., unpublished data). Independently 
of the immunoglobulin class, complexes 
involving MSP119 are kinetically rather stable 
with dissociation constants in the µM to sub-
nM range (15, 25, Lock and Holder, 
unpublished data). As the binding affinity is 
similar in all cases, it has been assumed that 
the inhibitory effect depends mainly on steric 
factors – namely, epitope location – rather 
than the nature of the antibody.  
The present study has been based on the 
structural homology of cupredoxins with the 
Fab fragment of an antibody, as well as on 
reports of a protein from this family 
interacting  directly with MSP119 and blocking 
the increase of parasitemia in human red 
blood cells infected by P. falciparum, 
suggesting a promising treatment (26,27). We 
first used used DaliLite pairwise comparison 
program to identify structural similarities 
between cupredoxins and the Fab fragment 
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(28). A screening was then performed 
combining NMR and ITC measurements with 
docking calculations using BiGGER which 
indicated that, among the cupredoxins tested, 
rusticyanin (Rc) provided the most effective 
binding to MSP119. While the two proteins 
form a well-defined complex where Rc 
interacts at the interface between the two 
MSP119 sub-domains, at a site that overlaps 
with the surface recognized by the inhibitory 
antibodies, P. falciparum growth is inhibited 
by the presence of Rc in red blood cell 
cultures. Interestingly, the copper site plays a 
key role in complex formation, since apo-Rc 
is not only unable to interact with MSP119, but 
also to inhibit parasite invasion and 
development in infected red blood cells. 
 
EXPERIMENTAL PROCEDURES 
Expression and purification of proteins– 
Plasmodium yoelii MSP119 (
15N-labeled or 
unlabeled) was produced [essentially as 
described previously (29)] from a synthetic 
gene optimized for Pichia pastoris expression 
using as nitrogen source either 15NH4Cl or 
(NH4)2SO4 for labeled and unlabeled protein, 
respectively. The 99-amino acid sequence 
corresponds to residues 1656-1754 of the 
UniProtKB entry P13828 containing the N-
terminal tag HHHHHHIEGR that has little 
effect on the NMR spectrum (20). Secreted 
hexahistidine-tagged MSP119 was purified 
from the culture medium by nickel affinity 
chromatography (Ni Sepharose 6 Fast Flow, 
GE Healthcare) and according to a previously 
elaborated protocol (12).  
All recombinant metalloproteins were 
expresed in Escherichia coli cultures in LB 
medium and purified according to previously-
elaborated procedures, namely 
Acidithiobacillus ferrooxidans Rc (30, 31), 
Nostoc sp. PCC 7119, Phormidium 
laminosum and poplar plastocyanins (Pc) (32-
34)  and Pseudomonas aeruginosa azurin (Az) 
(35). 
NMR spectroscopy– All protein samples 
were concentrated in 10 mM potassium 
phosphate (pH 6.5) using Millipore 3K 
NMWL centricons and microcons. MSP119 
samples ranged in concentration from 0.5 to 2 
mM, whereas cupredoxins were used in the 
range of 2 to 5 mM. All NMR samples 
contained 10% of D2O to adjust the lock 
signal. Reduction of the metal center in 
samples of copper (I) cupredoxins was 
achieved by adding sodium ascorbate, while 
oxidation of the metal center in samples of 
copper (II) proteins was achieved using 
sodium ferricyanide for Pc and Az, and 
sodium hexachloroiridate (IV) for Rc. In all 
cases, the proteins were extensively washed to 
remove the excess of the reducing/oxidizing 
agent. 
NMR experiments were performed in a 
Bruker Avance 600 MHz spectrometer at 25 
ºC. The sequence-specific assignment of the 
backbone amide groups of 15N MSP119 
(BMRB accession number: 19233) was 
achieved using standard backbone 
experiments  (HNCACB, HNCA, etc.) and 
was confirmed using 3D 1H-15N NOESY-
HSQC and 3D 1H-15N TOCSY-HSQC spectra. 
The interaction of MSP119 with cupredoxins 
was followed by acquiring two-dimensional 
1H-15N HSQC spectra during the titration of 
0.5 mM 15N-MSP119 solutions with an 
increasing amount of oxidized or reduced 
cupredoxins up to a final cupredoxin:MSP119 
molar ratio of 4:1. The pH value of the sample 
was verified after each titration step. Prolines, 
which are invisible resonances in 15N HSQC 
spectra, are located at the positions 4, 15, 50, 
61, 84 and 86, whereas Gly1, Val2, Glu69 and 
Asn73 are unassigned residues. All data 
processing was performed with Bruker 
TopSpin 2.0, and NMR analysis of line 
broadening perturbations of the cupredoxin-
bound MSP119 with respect to free malarial 
protein was performed in the SPARKY 
program (36). 
NMR linewidth analysis– To estimate 
linewidths, the peaks were fitted to a Gaussian 
function for the 15N and 1H dimensions using 
the program SPARKY with a 10,000 steps 
minimization and a 0.05% tolerance. 
In the analysis of the linewidths (∆ν1/2), 
the overall broadening (∆∆ν1/2) obtained from 
signals displaying only minor line broadening 
was first subtracted from the linewidth of the 
corresponding signal. Then, for each residue, 
the differences of linewidths between free and 
interacting MSP119 were calculated in every 
titration series (∆∆ν1/2 Binding). The threshold 
value, used to identify a specifically 
broadened residue when data from the 
titration series were analyzed together, was 
defined as the average ∆∆ν1/2 Binding for the 
system plus 2 standard deviations (2Sn-1). The 
average ∆∆ν1/2 Binding and standard deviation 
were calculated for all amides with values ≤ 
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10 Hz on the basis that data > 10Hz clearly 
indicated a specifically broadened residue and 
their inclusion would bias the average to a 
higher value. 
Some assigned signals of the free 
MSP119 HSQC spectrum overlap (Val9, 
Asn87 and Cys95) or exhibit very low 
intensity (Gly41 and Asn42), so they could 
not be properly integrated to include them in 
the linewidth analysis. 
ITC– All ITC experiments were 
performed using VP-ITC and Auto-ITC200 
instruments (Microcal, GE Healthcare) at 25 
ºC titrating Rc with MSP119. The reference 
cell was filled with distilled water. The 
experiments consisted of 10-µL or 2-µL 
injections of 0.3 mM MSP119 solution in 10 
mM potassium phosphate buffer pH 6.5 into 
the sample cell, initially containing 6.67 µM 
Rc solution - reduced, oxidized and apo forms 
- in the same buffer. All the solutions were 
degassed before the titrations were performed. 
Titrant was injected at appropriate time 
intervals to ensure the thermal power signal 
returned to the baseline prior to the next 
injection. To achieve homogeneous mixing in 
the cell, the stirring speed was kept constant at 
1000 rpm in the Auto-ITC200 and at 450 rpm 
in the VP-ITC. The data, specifically the heat 
per injection normalized per mole of injectant 
vs. molar ratio, were analyzed with Origin 7 
(Microcal) using a single-site binding model. 
Calibration and performance tests of the 
calorimeter were carried out conducting 
CaCl2–EDTA titrations with solutions 
provided by the manufacturer.  
Molecular Docking simulations– A soft 
docking algorithm implemented in the 
BiGGER software package (37) was used to 
determine in silico a model of the complexes 
MSP119-Az, MSP119-Pc and MSP119-Rc. The 
coordinates files of cupredoxins were 1JZG 
for Az (38), 1NIN for Pc (39) and 1A3Z for 
Rc (40). For each run, 5000 docking 
geometric solutions were generated based on 
the complementarity of the protein surfaces. 
These solutions were evaluated and ranked 
according to their “global score”, and different 
interaction criteria including electrostatic 
energy of interaction, relative solvation 
energy and the relative propensity of side 
chains to interact. For the MSP119-Rc adduct, 
NMR restraints were introduced in the 
docking calculations. All complexes graphic 
images were generated using the UCSF 
Chimera package (www.cgl.ucsf.edu/chimera; 
41). 
P. falciparum cultures– Synchronized P. 
falciparum 3D7 late stage trophozoites at 33-
36h were used. The final parasitemia and 
hematocrit were between 0.1-0.2% and 2% 
respectively. Red blood cells used for the 
assay were centrifuged to remove the buffy 
coat and washed twice in RPMI 1640 medium 
so that no white blood cells were present. The 
culture medium contained RPMI 1640 
supplemented with 5g/L albumax, 0.025g/L 
gentamycin, and 0.292g/L L-glutamine. 
P. falciparum growth inhibition assay– 
Sterile 96 well black tissue culture plates 
(Costar) were used routinely for every assay. 
The holo- or apo-species of Rc and Nostoc Pc 
were diluted in culture medium and used in 
duplicate wells for each dilution (200, 100, 50 
and 25 µM, respectively) in a final volume of 
100 µL per well. Two control sets were used 
in duplicate wells, one set with no added 
cupredoxin (positive control) and one with 
uninfected red blood cells (negative control). 
The plates were incubated at 37 ºC for 48h in 
a gas chamber flushed with 5% CO2,, 5% O2, 
and 90% N2.. After 48h, supernatants were 
removed from each well, replaced with fresh 
medium containing protein and incubated for 
a further 48h in the same manner. At the end 
of the 96h incubation, 25 µL of SYBR Green I 
dye (SYBR Green I  nucleic acid gel stain 
10000x, in DMSO from Invitrogen)  in lysis 
buffer (1 µL dye to 1 mL lysis buffer)  was 
added to each well and stored overnight at -20 
ºC. The lysis buffer contained Tris-HCl (20 
mM, pH8.0), EDTA (2 mM), Saponin (0.16 % 
w/v) and Triton X-100 (1.6 % v/v). Plates 
were thawed at room temperature and 
fluorescence intensity was measured with a 
FLUO Star Omega microplate fluorescence 
reader (BMG Labtech). Values were 
expressed in relative fluorescence units. 
Binding of SYBR Green is specific for 
parasite DNA as mature erythrocytes lack 
DNA and RNA. Fluorescence intensity unit 
was converted to percentage (%) of growth as 
follows: % growth = (culture under Rc or Pc) 
– (uninfected RBC) /  (culture with no Rc or 
Pc) – (uninfected RBC) x 100, where RBC are 
red blood cells. 
 
RESULTS 
Structural similarities between 
cupredoxins and the Fab fragment of a mAb– 
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The Fab fragment crystal structure of mAb 
G17.12 (15), shown to bind MSP119, is 
constituted of two domains, A and B, 
containing two regions, variable (symbolized 
by 1) and constant (symbolized by 2), with the 
canonical β–sandwich fold of the 
immunoglobulin superfamily (Figure 2A). 
Consistent with previous reports, the DaliLite 
pairwise comparison program (28) identified 
significant structural similarities between the 
A1 fragment of the mAb and copper-
containing redox proteins with 
immunoglobulin fold, such as Az, Pc and Rc. 
In particular, the structural alignment between 
the A1 fragment and Az reveals a matching 
region, which is mainly localized at the two 
antiparallel β-sheets, as described previously 
(26; Figure 2B), and with a Dali Z-score of 
2.9. For the two other cupredoxins, Pc and Rc, 
this structural match is extended to the loops 
connecting β strands yielding Z-scores of 3.1 
and 2.6, respectively (Figure 2C).   
Given the structural similarity between 
various cupredoxins and the Fab fragment, ab 
initio docking approaches were performed 
with no experimental restraints (Figure 3) to 
explore the capability of the metalloproteins 
to interact with MSP119 from P. yoelii. 
MSP119 is well-conserved among the species 
with more than 50% sequence identity (Figure 
1A), with conserved three-dimensional 
structure and common functional features 
(17). We used the BiGGER rigid docking 
algorithm to generate sets of possible 
orientations for the different cupredoxin 
probes around MSP119 (the target). Figure 3 
shows the distribution of MSP119 mass centers 
resulting from the 100 best solutions from 
each computation around the corresponding 
copper protein. For Az and Pc, we observe a 
remarkably broad dispersion of the MSP119 
geometry centers, suggesting the lack of 
specific surface complementarity. By contrast, 
molecular docking for the Rc-MSP119 
interaction indicates that MSP119 explores a 
well-defined area of Rc surrounding its copper 
center. 
MSP119 interactions with cupredoxins 
by NMR– The MSP119-cupredoxin interaction 
was monitored by recording 2D 15N-HSQC 
NMR spectra on 15N MSP119, both free and 
following the addition of Az, Pc or Rc. The 
absence of changes in MSP119 resonances – 
either chemical shift perturbations or line 
broadening – indicates no detectable binding 
to Az and Pc in any of their oxidation states 
(Figure 4, upper and middle panels). By 
contrast, linewidth changes of certain MSP119 
amide signals upon addition of Rc(Cu1+) 
suggest a specific MSP119-Rc  interaction 
(Figure 4, lower panel). Such observations 
coincide with ab initio docking simulations 
performed (Figure 3) which suggested a well-
defined complex only between Rc and 
MSP119. 
To probe in greater detail the interaction 
of MSP119 with either oxidized or reduced Rc, 
we analyzed the linewidths of MSP119 
resonances from 15N-HSQC spectra across 
several titrations. Binding to Rc results in 
general signal broadening due to the increase 
in the rotational correlation time of MSP119 
when interacting with Rc. In addition, several 
MSP119 backbone amides clustered in one 
area of the structure undergo larger changes in 
linewidths (∆∆ν1/2 Binding) upon Rc binding 
(Figure 5, Figure 6). These resonances are 
expected to be at or in the proximity of the 
area of MSP119 interacting with Rc. In order to 
selectively define resonances most likely to be 
part of the interface, threshold values – 
specifically, ∆∆ν1/2 Binding  ≥ 5Hz for 
15N and ≥ 
11Hz for 1H dimension – were set 
(Experimental Procedures). As expected, the 
distribution of  linewidth changes (∆ν1/2)  
becomes broader as the Rc:MSP119 ratio 
increases (data not shown). 
At the Rc(Cu1+):MSP119 ratio of 1.5:1, 
14 amino acids show considerable 15N 
linewidth changes in MSP119 HSQC spectra 
(Figure 5A and 5B). These residues are 
mainly distributed along two regions of 
MSP119, namely, at the beginning of N-
terminal EGF domain involving Asp3, Lys5, 
His6, Val7, Asp10 and at the end of C-
terminal domain comprising Thr85, Ala88, 
Tyr89, Phe94, Ser97. In addition, Asp24, 
Asp25 and Arg31 at the two first antiparallel 
β-strands, along with Cys59, are also altered. 
Figure 5C shows the map of MSP119 residues 
affected by Rc addition, with colors 
corresponding to line broadening in the 15N 
dimension. The sequential stretches of 
residues detailed above form the main cluster 
on the MSP119 surface, which surrounds the 
two EGF domain interface. Interestingly, 
some of these affected residues – Asp24, 
Asp25, Arg31 and Cys59 – are located at the 
rear of the protein (Figure 5C). While Asp24 
and Asp25 are close to amino acids at the N-
/ 
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terminal, Arg31 and Cys59 lie near Phe94. 
Since these four residues are adjacent to 
others placed at the EGF domain interface and 
involved in direct contact with Rc, these 
linewidth perturbations are probably a 
secondary effect of binding. Similar 
conclusions may be inferred from 1H 
linewidth analysis, although protons are more 
sensitive to broadening (data not shown).  
NMR titration of oxidized Rc on 
MSP119 results in significant MSP119 
linewidth perturbations at a Rc(Cu2+):MSP119 
ratio of 4:1, at which some signals broaden 
beyond the detection limit (Figure 6A). The 
MSP119 resonances affected by Rc(Cu
2+) 
binding involve both N-terminal (Asp3, Lys5, 
Asp10, Asp13) and C-terminal (Cys79, Thr85, 
Tyr89, Gly92, Phe94, Ser97, Ser98) regions, 
as described for the reduced system at a 
Rc(Cu1+):MSP119 ratio of 1.5:1. An additional 
stretch (Phe21-Asp24, Gly26, Glu29, Arg31 
and Cys59) is also perturbed while His6, 
Val7, Asp25 and Thr27 were residues over the 
detection limit (Figure 6A). Notably, the 
strength of the broadening observed for a 4:1 
Rc(Cu2+):MSP119 ratio is comparable to the 
one observed at a 1.5:1 Rc(Cu1+):MSP119 
ratio, indicating that MSP119 bind more 
weakly to the oxidized Rc. However, the 
MSP119 interacting surface involved in Rc 
recognition at a Rc:MSP119 ratio of 4:1 is 
independent of the cupredoxin redox state 
(Figure 6). 
Binding of MSP119 to holo-Rc by ITC– 
ITC measurements reveal that MSP119 binds 
to Rc either in its reduced or oxidized state 
with a 1:1 stoichiometry at 25 ºC (Figure 7). 
Notably, the interaction of MSP119 with 
Rc(Cu1+) is exothermic with a dissociation 
affinity constant (Kd) of 2 µM, whereas that 
with Rc(Cu2+) is an endothermic process with 
lower binding affinity (Kd = 25 µM) (Table 1). 
Such differences in Kd values are in agreement 
with NMR titrations and suggest that MSP119 
binds to reduced Rc with a greater affinity 
than to oxidized Rc. Further experiments need 
to be performed to explain the opposite sign in 
the enthalpy of both processes as it could be 
related to (i) changes in the 
protonation/deprotonation equilibrium of 
ionizable groups of the interacting proteins; 
(ii) variations in the hydrogen-bonding 
networks; (iii) differences in water 
arrangement in the vicinity of oxidized or 
reduced cofactors; and (iv) slight 
conformational modifications altering the 
number of solvent molecules excluded from 
the protein interface. 
The case of apo-Rc– To determine the 
role of the copper center, NMR and ITC 
titrations were carried out using MSP119 and 
apo-Rc. Surprisingly, NMR titrations showed 
no substantial linewidth changes even at an 
apo-Rc:MSP119 ratio of 4:1 (Figure 8). The 
finding was further corroborated by ITC 
measurements, as the weak calorimetric 
profile suggests a lack of interaction (Figure 
8). Altogether these data indicate the 
relevance of the copper center in the binding 
to MSP119. Despite the small structural 
differences in cupredoxins reported previously 
in solid state, there exists a high degree of 
mobility of the metal-binding loops in 
solution in the apo form, as recently 
demonstrated by NMR (42,43). The different 
pattern between apo and holo-Rc versus 
MSP119 could be related with the found 
differences in the dynamics of this site in the 
two forms. 
Docking simulations with BiGGER– 
Along with the ab initio docking calculations 
run on the MSP119/Rc(Cu
1+) complex, 
revealing how the MSP119 mass center docks 
on the Rc metal crevice (Figure 3), an NMR-
restrained docking with BiGGER was also 
performed. Linewidth data for those MSP119 
residues in contact with Rc at a Rc:MSP119 
ratio of 1.5:1 were included in the run. The 
output is a set of docked solutions that can be 
ranked according to the BiGGER global score 
or individual scores, such as hydrophobic 
criteria, electrostatics and geometrical 
parameters. Figure 9 shows the best 100 
solutions, as represented by Rc geometry 
centers, according to the global and 
hydrophobic scores from the program (Figure 
9A). The best-scoring models predicted by 
restrained docking reveal how MSP119 leans 
its EGF-domain interface to approach Rc 
(Figure 9A). Indeed, the proximity of the 
surfaces on both proteins in the complex is 
shown in the space-filling representation 
(Figure 9A). In addition to the copper center, 
loops connecting Rc β-strands are in close 
contact with MSP119. A deep analysis of the 
complex interface predicted by docking points 
to the N-terminal and C-terminal regions of 
the MSP119 as driving complex formation as 
some NMR restraints are satisfied (Figure 
9B). In the model reported, some electrostatic 
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interactions occur (Figure 9C) since Rc 
residues Lys81 and Lys116 are close to Glu91 
and Glu83 in MSP119. Furthermore, Lys5 of 
MSP119 can interact with Glu9 of Rc, 
although the Glu is partially buried. The Rc 
interaction surface is mainly hydrophobic with 
the exception of a single positive spot, Lys81 
and Lys116, surrounded by Phe83, Gly82 and 
Trp7 and the copper center, which, in turn, is 
enclosed by Met99, Val98 and Pro141. This 
interaction mode resembles those of the 
copper protein Pc and cytochrome c6 (Cc6) 
with their photosynthetic partners, cytochrome 
f and photosystem I. In such complexes, Pc 
and Cc6 use the hydrophobic site surrounding 
the copper center and the heme group – site 1 
– as well as their charged patch (site 2; 44,45).  
Inhibition of P. falciparum growth by 
holo-Rc– To assess the physiological 
relevance of the MSP119 binding to Rc, the 
growth of P. falciparum – within red blood 
cells – was followed in the presence of either 
holo- or apo-Rc (Experimental Procedures). 
The addition of holo-Rc to infected cells 
resulted in parasitemia inhibition, as culture 
growth decreased significantly (Figure 10) at 
a concentration of 100 µM till the point of 
complete inhibition at 200 µM of holo-Rc. In 
contrast, the apo form even at high 
concentrations did not have a significant 
effect on P. falciparum growth. These data 
fully corroborate previous observations using 
NMR or ITC as much as apo-Rc is unable to 
bind to MSP119.  
In order to discard that such a 
parasitemia inhibition could be ascribed to the 
well-known apoptotic role of several 
cupredoxins (46,47), control experiments 
were run with the holo- and apo-forms of Pc. 
Holo-Pc was chosen as it does not bind to 
MSP119, as inferred from the herein presented 
NMR screening (see above), but it is 
structurally very similar to Rc: the two 
proteins belong to the Type I blue copper-
protein family, with almost identical folding 
and tetrahedral copper center. Upon addition 
of either holo- or apo-Pc (25 µM) under the 
same culture conditions, the Plasmodium 
growth first slightly decays to further reach a 
constant value until the end of the experiment. 
So the Plasmodium growth does not depend 
on protein concentration (the percentage of 
growth is maintained at ca. 70% even at 200 
µM Pc), and is practically the same with 
either holo- or apo-Pc. Altogether these results 
indicate that holo-Rc inhibits parasitemia 
upon specific binding to MSP119. 
 
 
DISCUSSION 
Proteins from the cupredoxin family 
have demonstrated antimalarial activity and 
potential as therapeutic agents (26,27). We 
have shown here that the cupredoxin 
rusticyanin interacts with MSP119 with 
micromolar Kd, forming a well-defined 
complex. The interaction takes place on the 
same surface as that targeted by inhibitory 
antibodies, suggesting that a similar 
mechanism could take place. Its strength is 
dependent on the presence and, to a lesser 
extent, on the oxidation state of the metal 
center, which is consistent with the need for 
an intact interaction surface and charge 
conservation. Furthermore, we have observed 
the inhibition of P. falciparum parasitemia in 
infected cells where holo-Rc is present as a 
result of the interaction with MSP119. 
However, negligible effect on parasite growth 
could be observed for apo-Rc and Pc forms. 
MSP119 signals show slow exchange in 
the presence of the Fab fragments of the 
inhibitory mAb12.8 and mAb12.10, indicating 
the kinetic stability of complexes involving 
MSP119 with binding affinity constants in the 
µM to sub-nM range (20). Rc binds 
specifically with a Kd of 2 µM to the interface 
between the two MSP119 EGF domains, 
overlapping the surface recognized by these 
inhibitory antibodies (20,21), as indicated by 
our NMR-based mapping. A detailed 
comparison of MSP119 bound to either Rc or 
mAb12.10 and mAb12.8 reveals that the 
common interacting surfaces are located in the 
first EGF domain along with the first β-sheet 
and at the end of the second EGF domain. 
Interestingly, these regions of MSP119 form a 
shallow pocket (Figure 1B) that may have a 
role in erythrocyte invasion (21). In addition, 
these residues involved in the formation of 
protein complexes with MSP119 are 
distributed in three segments –  His6-Val9, 
Lys16-Arg22 and Tyr89-Cys95 (numbering 
according to the P. yoelii MSP119 sequence, 
Figure 1A) – and they are strongly conserved 
in different species (21), supporting the idea 
that this is a functional site. The presence of 
additional perturbed residues identified in this 
study may be explained by the flat structure of 
MSP119 (5), since perturbations as a result of a 
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protein-protein interaction may be transferred 
from one MSP119 face to the other. 
Another point of interest arising from 
this study is the mode of interaction of 
MSP119 with Rc, compared to the interaction 
with mAbs. The study took as starting point a 
structural alignment of Rc with the Fab 
fragment of the non-inhibitory mAb G17.12 
whose interaction with MSP119 has been 
solved through X-ray crystallography (15). 
The similarities with the β-barrel, as well as 
the loops connecting them, are clear (Figure 
2). However, the relative orientation between 
the mAb and MSP119 does not match that 
defined for the MSP119-Rc complex (Figure 
11A). In contrast, the models of mAb12.8-
MSP119 and mAb12.10-MSP119 complexes 
built by Autore et al. (48) using NMR-based 
docking calculations match well with the Rc-
MSP119 model reported here. In looking for 
structural similarities between Rc and 
mAb12.10 with the DaliLite pairwise 
comparison server, the Z-score 2.8 (Figure 
11B and 11C) suggested strong structural 
similarities, especially in the loops that 
interact with MSP119. In this paper, MSP119 
complexes with mAb12.10 and Rc 
demonstrate (Figure 11) a similar MSP119 
orientation with respect to the other molecule 
– mAb12.10 or Rc – within each complex. 
The A1 region of mAb12.10 forms the main 
interaction with MSP119, similar to the 
structurally-related region of Rc, especially at 
the level of β-strand connecting loops. As 
proposed by Autore et al. (48), a positively-
charged electrostatic spot on the antibody 
surface is required in the interaction and 
binding to MSP119. A similar positively-
charged area is located on the Rc surface –  
Lys81 and Lys116 – in the complex interface, 
as inferred from our docking simulations 
(Figure 9C). The Rc-MSP119 interface also 
involves hydrophobic contacts in the region 
surrounding the Rc copper center that 
presumably plays a key role in complex 
formation, as indicated by the NMR and ITC 
experiments. Reduced Rc binds more 
efficiently MSP119 than the oxidized form, 
suggesting that both electrostatic potential 
properties and protein folding depend on the 
metal redox state. This effect is even more 
drastic for apoRc, which is unable to interact 
with MSP119. 
The practical significance of these 
observations can be found in the potential 
antimalarial role of the binding of Rc to 
MSP119 on the parasite surface, thereby 
blocking parasite growth and interfering 
directly with parasite invasion of red blood 
cells. In fact, the interaction might sterically 
interfere with the recognition between MSP1 
and an erythrocyte surface molecule or with 
the proteolytic processing of MSP1, which 
occurs during invasion and can be inhibited by 
antibodies binding to MSP119.  Such a role has 
been shown previously in the drug suramin 
(49). An alternative hypothesis, based on the 
fact that MSP119 is internalized with the 
malaria parasite during invasion and then 
trafficked to the food vacuole where it persists 
until the end of the next intraerythrocytic 
cycle (10), is that MSP119-bound Rc would be 
internalized and interfere with MSP119 
functioning inside the cell, as shown for an 
antibody (11). Supporting this possibility, it 
has been reported that Rc is not only able to 
enter mammalian cells, but also to induce 
caspase-8 mediated apoptosis and/or to inhibit 
the cell cycle (47). Furthermore and unlike 
other cupredoxins, Rc is a copper protein with 
high acid stability and is biologically 
functional at a pH below 1.0 (50). The 
extreme acid stability of Rc may be important 
in understanding its function of blocking 
MSP119 since pH is approximately 4.5-5.5 
inside the Plasmodium food vacuole. 
Altogether, Rc could be an excellent 
therapeutic tool for malaria treatment and 
expand our understanding of MSP119 function. 
In this way, as well, it could provide 
beneficial information for drug design.  
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FIGURE LEGENDS 
 
FIGURE 1.  MSP119 protein.  (A) Multiple sequence alignment of MSP119 with ClustalW2 
(18) from a number of Plasmodium species. Sequences are colored by percent identity: black 
(100%), dark grey (80%), light grey (60%) and white (<50%). Secondary structure elements of 
P. yoelii MSP119 are shown. Orange boxes highlight cysteine residues that are conserved across 
different Plasmodium species, whereas red boxes highlight those present only in P. falciparum. 
Gold arrows stand for disulphide bonds formed by cysteine residues. The main difference 
between P. falciparum MSP119 and homologues from other Plasmodium species characterized 
to date lies in the disulphide-bond pattern of the protein from the other species: one of the 
cysteine pairs in the first EGF domain is substituted by a tryptophan and a non-polar or aliphatic 
residue. (B) Ribbon representation of the lowest energy NMR structure of P. yoelii MSP119 
(BMRB accession number: 19233). Side-chains of cysteine residues forming disulphide bridges 
are represented in gold.  
 
FIGURE 2. Conserved structural motifs. (A) Ribbon representation of the Fab fragment of 
G17.12 monoclonal Antibody (mAb; 1OB1.pdb). Domain A is depicted in light grey and 
domain B in gold. (B) Structural alignment of Az (upper, 1JZG.pdb) and A1 fragment of Fab 
(lower) built by DaliLite pairwise comparison server. Matching regions - with a Dali Z-score of 
2.9 - appear in orange. (C) Ribbon representation of Rc (upper, 1A3Z.pdb) and Pc (lower, 
1NIN.pdb). Dali Z-scores for Rc and Pc are 2.6 and 3.1, respectively. Copper atoms are colored 
in blue.  
 
FIGURE 3. Ab initio docking of cupredoxins with MSP119 performed by BiGGER. Left - 
Az. Center - Pc. Right - Rc. Light yellow spheres represent the geometry centers of MSP119 in 
the 100 best solutions generated for each complex. All cupredoxins are oriented with respect to 
their copper center. Robertson diagrams of the cupredoxins are colored according to secondary 
/ 
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structures: α helices in red and β strands in blue. Copper atoms are represented as blue spheres 
and the residues bonding to them are in grey sticks. 
 
FIGURE 4. NMR titrations of 
15
N MSP119 with reduced cupredoxins. Upper - Az from 
Pseudomonas aeruginosa. Middle - Pc from Nostoc sp. PCC 7119. Lower - Rc from 
Acidithiobacillus ferrooxidans. Superimposition of 15N HSQC spectra of free MSP119 (magenta) 
and after adding one out of three cupredoxins (blue) at a cupredoxin:MSP119 ratio of 4:1. 
Arrows point out those residues which experience substantial broadening. Negligible binding to 
MSP119 was observed upon adding aliquots of Pc and Az. 
 
FIGURE 5. NMR titration of 15N MSP119 with reduced Rc. (A) 
15N linewidth differences 
(15N ∆∆ν1/2Binding) between free and Rc-bound MSP119. The Rc:MSP119 ratios are 0.5:1 (red), 1:1 
(grey) and 1.5:1 (blue). (B) Superposition of 15N HSQC spectra of free MSP119 (magenta) and 
bound to Rc (blue) in a Rc:MSP119 ratio of 1.5:1. A subset of three representative resonances is 
labeled in black. (C) Map of MSP119 interface upon binding to Rc. MSP119 surface is rotated 
90º around the vertical axes in each view. Residues are colored according to their 15N 
∆∆ν1/2Binding (Hz): the resonances that undergo the largest broadening (≥ 5Hz) are orange and the 
signals with a significant linewidth over the detection limit < 5Hz are yellow. The limit of 5 Hz 
corresponds to a threshold value relative to the average plus 2-fold the standard deviation 
(∆∆ν1/2Binding ≥ ‹ ∆∆ν 1/2 Binding› + 2Sn-1). Residues with no linewidth perturbation are marked in 
blue, whereas prolines are in grey.  
 
FIGURE 6. Comparison between NMR titrations of 
15
N MSP119 with either oxidized or 
reduced Rc at Rc:MSP119 ratio of 4:1. Most of the MSP119 signals in binding to Rc(Cu
1+) are 
broadening over the detection limit at the Rc:MSP119 ratio of 4:1, suggesting that MSP119 binds 
reduced Rc with a higher affinity. (A) Upper: Overlap between 15N HSQC spectra of free 
MSP119 (magenta) and oxidized Rc-bound MSP119 (blue). Lower: Map of MSP119 in the 
presence of oxidized Rc. (B) The same as 6A with reduced Rc. The 90º-rotated surface 
representations of MSP119 show residues colored according their 
15N ∆∆ν1/2 Binding following the 
same color-code as in Figure 5C. Those residues broadened beyond the detection limit are 
highlighted in red.  
 
FIGURE 7. ITC titrations of MSP119 with both redox states of Rc. Binding assays of the 
complexes between MSP119 and reduced (left) or oxidized Rc (right). Thermograms are shown at 
the top and binding isotherms at the bottom, along with the dissociation constant (Kd expressed in 
µM), enthalpy (∆H in kcal/mol). The stoichiometry value (n) was fixed to avoid degeneracy in 
the non-linear regression data analysis. Typical relative errors are 20-25% for the dissociation 
constant and 5-10% for the stoichiometry. 
 
FIGURE 8. NMR and ITC titrations of MSP119 with apo-Rc. (A) 
15N linewidth differences 
(15N ∆∆ν1/2Binding) between free MSP119 and in the presence of apo-Rc. The apo-Rc:MSP119 ratios 
were 1:1 (red), 1.5:1 (grey) and 4:1 (blue). (B) Overlap between 15N HSQC spectra of free 
MSP119 (magenta) and in the presence of apo-Rc (blue) at an apo-Rc:MSP119 ratio of 4:1. (C) 
ITC thermogram obtained from the apo-Rc-MSP119 titration, revealing the lack of binding 
between both proteins, because of the flat calorimetric profile.  
 
FIGURE 9. BIGGER molecular docking of the MSP119-Rc complex. (A) Left - Best 100 
models with the lowest energy values after alignment of MSP119 molecules with Rc geometry 
centers represented by spheres. Ribbon (center) and space-filling (right) representations for the 
best model are shown in the same orientation as on the left. MSP119 is represented in dark grey 
whereas Rc is in light blue. (B) Interface residues of the MSP119/Rc complex. MSP119 and Rc 
are independently rotated 90º to the top and to the bottom, respectively, with regard to their 
orientation in A. Contacting residues are depicted in light yellow for the MSP119 and dark blue 
for Rc. (C) Electrostatic potential surfaces of MSP119 (upper) and Rc (lower) with the same 
orientations as in B. The electrostatic potential surfaces were created with a color ramp for 
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positive (blue) and negative (red) potentials at 300 mM ionic strength. The potentials were 
calculated in Chimera software (41). 
 
FIGURE 10. Inhibition of P. falciparum growth by Rc. Percentage of parasite growth was 
measured in the presence of either holo-Rc (filled circles), apo-Rc (open circles), holo-Pc (filled 
stars) or apo-Pc (open stars) at varying concentration (see Experimental Procedures). Parasite 
cultures were incubated with the Rc or Pc forms for a 96 h-period, with a medium change after 
48 hours. Cultures in the absence of cupredoxin were used as a positive control. 
 
FIGURE 11. Comparison of complexes containing MSP119. (A) MSP119/mAbG17.12 
crystallographic structure (1OB1.pdb; 15). Domain A1 of the non-inhibitory mAbG17.12 is 
represented in light grey, whereas P. falciparum MSP119 is in purple. (B) MSP119/mAb12.10 
complex, whose PDB coordinates were kindly provided by Fraternali and coworkers (48). 
Domain A1 of the inhibitory mAb12.10 and P. falciparum MSP119 were colored as in A. (C) 
MSP119/Rc complex studied in this work. P. yoelii MSP119 is depicted in dark grey and Rc in 
light blue. Copper center is represented by a blue sphere. Matching regions between 
mAbG17.12 or mAb12.10 and Rc after structural alignment using DaliLite were depicted in 
orange. The 180º-rotated views for both MSP119/mAb12.10 and MSP119/Rc complexes are 
shown.  
 
TABLE 1. Thermodynamic values inferred from ITC experiments. 
MSP119 
complex 
∆G 
(kcal/mol) 
∆H 
(kcal/mol) 
−Τ∆S 
(kcal/mol) 
Kd 
(µM) 
Oxidized Rc -6.8 15 -21.8 20 
Reduced Rc -8.4 -1.7 -6.7 2 
 
The affinity of a protein-protein interaction is defined by the Gibbs energy of the binding: ∆G= -RT ln Ka. 
∆G has two different contributions, ∆H and ∆S, according to the equation: ∆G= ∆H-T∆S, thus several 
combinations of those values could yield similar binding affinities. The complex formation is entropically 
driven in both cases, being the enthalpic contribution to the binding unfavorable (15 kcal/mol with 
oxidized Rc) or only slightly favorable (-1.7 kcal/mol with reduced Rc). 
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